Tox EG, Ethanol, Methanol-3

ETHYLENE GLYCOL, METHANOL, & ETHANOL TOXICITY

Presenter: Melissa Bucknoff, DVM, DACVECC, Assistant Professor of Biomedical Sciences & Clinical Pharmacology, Ross University School of Veterinary Medicine.

OBJECTIVES

  • Mechanisms of Toxicity: Understand the detailed toxicity mechanisms for ethylene glycol, methanol, and ethanol, focusing on their metabolic pathways and targeted organs.

  • Lab Findings: Identify common laboratory work findings associated with ethylene glycol toxicity, including specific biochemical markers that indicate the severity of poisoning.

  • Diagnosis: Understand the comprehensive steps involved in diagnosing cases of toxicity, utilizing both clinical signs and laboratory data.

  • Acute Kidney Injury: Discuss acute kidney injury (AKI) in the context of ethylene glycol toxicity, including the time frames for onset and the pathophysiological processes involved.

  • Antidote: Identify the specific antidote for ethylene glycol toxicity (fomepizole) and delineate its mechanism of action.

  • Treatment Approach: Discuss multifaceted treatment approaches for ethylene glycol, methanol, and ethanol toxicities, including the role of supportive care and renal function management.

  • Prognosis: Understand prognosis related to these toxicities, acknowledging factors influencing recovery after poisoning incidents.

ETHYLENE GLYCOL PROPERTIES

  • Chemical Formula: Dihydric alcohol (HO-CH2-CH2-OH).

  • Physical Properties: Readily soluble in water, significantly lowers the freezing point, possesses a small molecular weight, contributing to its widespread use in various products.

  • Additives: Some commercial antifreeze products contain phosphate rust inhibitors, which can also pose additional toxicological concerns.

  • Characteristics: Sweet-tasting (highly attractive to animals), colorless (often artificially colored in commercial products), and odorless liquid, enhancing the risk of accidental ingestion by pets.

  • Danger: Considered extremely deadly; poses severe poisoning risks to animals due to its low lethal dose and the insidious nature of its effects.

ETHYLENE GLYCOL (EG) EXPOSURE & SOURCES

  • Primary Source: The ingestion of antifreeze-containing products due to the appealing sweet taste is the primary cause of poisoning incidents.

  • Other Sources: Pets may also be exposed through drinking from antifreeze puddles, leakage from vehicles, other industrial products including hydraulic brake & transmission fluids, industrial solvents, wood stains, paints, rust removers, color film processing fluids, snow globes, various heat-exchange fluids, motor oil, windshield de-icing agents, and cases of mal-intent poisoning.

  • Comparative Safety: Although propylene glycol antifreeze is considered less toxic, it still poses certain health risks, thus care must be taken with all antifreeze products.

ETHYLENE GLYCOL TOXICITY

  • Prevalence in Pets: Ethylene glycol poisoning is very common in dogs and cats and is recognized as the second most common fatal poisoning in domestic animals.

  • Statistics: Annually, 10,000-45,000 fatal poisoning cases are reported in dogs, with a mortality rate between 59-70%; lethal doses for both species are alarmingly minimal.

  • Lethal Dose (Cats): Approximately 1.4-4 ml/kg (~1 teaspoon). Example: An 8 lb cat may ingest as little as ~5 ml to reach lethal toxicity.

  • Lethal Dose (Dogs): Approximately 4-6.6 ml/kg.

  • Mechanism: Toxicity arises from the metabolites of ethylene glycol that cause systemic toxicity, primarily targeting the renal system, leading to significant renal damage.

TOXICOKINETICS

  • Absorption: Ethylene glycol is rapidly absorbed from the gastrointestinal tract; the presence of food delays absorption significantly.

  • Distribution: Once absorbed, ethylene glycol is quickly distributed throughout the body tissues, including vital organs such as the central nervous system (CNS).

  • Half-life: Approximately 3-4 hours in dogs, with even shorter half-lives observed in cats, necessitating prompt medical intervention.

  • Metabolism: Metabolized in the liver to toxic metabolites, exhibiting potential changes to zero-order elimination kinetics at high doses, complicating treatment efforts.

MECHANISM OF ACTION

  • Toxic Metabolites: Ethylene glycol undergoes oxidation by alcohol dehydrogenase to form glycoaldehyde, which is further metabolized to glycolic acid, glyoxylic acid, and oxalic acid, among others.

  • End Products: Other toxic metabolites include formic acid, hippuric acid, and benzoic acid, each contributing to varied pathophysiological effects during toxicity.

HEPATIC LETHAL BIOTRANSFORMATION & RENAL EXCRETION

  • Excretion: Minimal amounts of ethylene glycol are excreted unchanged by the kidneys, as the majority undergoes metabolism.

  • Toxic Metabolites Formation: The formation of harmful metabolites such as glycolic acid, glycoxylate, and glycoaldehyde are primarily responsible for the observed toxicity in parallel with renal damage.

TOXIC EFFECTS OF METABOLITES

  • Toxicity Severity: Highly toxic metabolites like glycoxylate and glycoaldehyde, despite having short half-lives, contribute significantly to intoxication levels.

  • Glycolate: Possesses a longer half-life, which contributes to the accumulation of overall toxicity during prolonged exposure.

  • Oxalic Acid: The main end product of ethylene glycol metabolism; it binds to serum calcium to form insoluble calcium oxalate crystals in tissues, leading to hypocalcemia and resultant clinical signs.

  • Calcium Crystals: Detection of calcium oxalate crystals can persist for several days post-ingestion and are considered pathognomonic for EG toxicity, highlighting the importance of clinical recognition.

TOXICOSIS & CLINICAL SIGNS

  • CNS Effects: Symptoms such as depression, ataxia, seizures may manifest within 30 minutes post-ingestion, leading to significant neurological impairment in severe cases.

  • Gastrointestinal Effects: Vomiting can result from mucousal irritation in the gastrointestinal tract as a direct effect of the toxic compounds.

  • Acute Kidney Injury (AKI): EK toxicity frequently leads to AKI, which is a major systemic manifestation alongside uremia, adversely affecting overall health outcomes.

CLINICAL SIGNS BY SYSTEM

  • Respiratory: Signs of tachypnea and hypoventilation are more commonly observed in dogs compared to cats, indicating potential respiratory compromise.

  • Cardiovascular: Toxicity may lead to arrhythmias, decreased cardiac output, hypocalcemia, and metabolic acidosis complicating the clinical picture.

  • Renal: Onset of AKI typically occurs within 24-72 hours post-ingestion; hallmark signs include oliguria (reduced urine output) and anuria (absence of urine output), indicating severe renal dysfunction.

MECHANISM OF NEPHROTOXICITY

  • Cytotoxicity: The metabolites generated cause direct damage to renal tubular epithelium. Additional calcium oxalate crystal formation leads to acute tubular necrosis further aggravating renal injury.

  • Damage Correlation: The level of renal damage may not directly correlate with the number of crystals seen in the renal system, reiterating the complexity of the toxic process.

DIAGNOSIS OF ETHYLENE GLYCOL TOXICITY

  • Importance of Early Recognition: Recognizing the signs of ethylene glycol poisoning early is essential for effective management and improved outcomes.

  • Clinical Signs: Signs can be dose-dependent, indicating potential effects of unmetabolized ethylene glycol or its metabolites, guiding the direction of treatment.

CLINICAL COURSE OF TOXICITY

  • Early Signs (30 min - 12 h): Symptoms may include CNS depression, nausea, ataxia, polyuria, dehydration, and potentially progress to coma or death, depending on exposure levels.

  • Late Signs (24-72 h): Patients typically present with oliguria, severe lethargy, and renal pains as the toxicity progresses into critical stages.

STAGES OF TOXICITY

  • Stage I (1-3 hrs): Early signs include rapid GI absorption leading to narcosis (drowsiness) and euphoria, often mistaken for other conditions.

  • Stage II (4-6 hrs): Severe acidemia develops due to the accumulation of toxic metabolites, with increased acid levels affecting blood pH.

  • Stage III (6-12 hrs): Renal toxicity becomes apparent, with signs of crystal formation in the urine indicating serious renal dysfunction.

LABORATORY FINDINGS

  • Serum Changes: Increased serum osmolality and an anion gap typically characterized in ethylene glycol toxicity.

  • Critical Levels: Anion gap greater than 40-50 mmol/L indicates severe toxicity and can rise in the first 3-6 hours post-ingestion, serving as an important diagnostic marker.

ADDITIONAL LAB FINDINGS

  • Hemoconcentration: Evidence of increased packed cell volume (PCV) and total protein levels due to dehydration is common in acute case presentations.

  • Metabolic Acidosis: A blood pH below 7.3 and common occurrence of hypocalcemia can further complicate the clinical status of affected animals.

  • Acute Kidney Injury: Demonstrated by increased creatinine and blood urea nitrogen (BUN) levels, indicating considerable renal impairment.

TREATMENT

  • Hemodialysis: This is considered effective for the decontamination and removal of ethylene glycol and its metabolites, with best outcomes seen if administered before the onset of renal failure.

  • Fomepizole: Identified as the specific antidote; it acts as a competitive inhibitor of alcohol dehydrogenase, thereby preventing the toxic metabolic transformation.

  • Ethanol Protocols: Though ethanol can be used as an alternative treatment, it is less ideal compared to fomepizole due to various challenges associated with its administration.

SUPPORTIVE THERAPY & MONITORING

  • IV Access: Prompt initiation of fluid therapy to maintain hydration and support renal function is vital in therapeutic management.

  • Electrolyte Monitoring: Essential for careful monitoring of urine output and body electrolytes to prevent further complications.

PROGNOSIS

  • Dependence on Timing: The timing of treatment significantly influences prognosis; early intervention typically results in better outcomes, whereas delayed treatment leads to a poor prognosis, especially if anuria is present.

  • Long-Term Recovery: While recovery is possible with appropriate management of renal function post-acute injury, some animals may experience lasting renal impairment requiring ongoing care.

SUMMARY OF ETHYLENE GLYCOL & ALCOHOL TOXICITY

Prompt recognition and immediate care are critical for the management of toxicity cases. Treatment goals include timely decontamination, the administration of specific antidotes, and supportive care to improve the chances of recovery and minimize long-term effects.